Autonomix Secures Canadian Patent for Neural Sensing
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
COLLEGE STATION, Texas, July 6, 2026 Matica Biotechnology, Inc. (Matica Bio) has entered into a strategic partnership with VaxDome...
NEW YORK, July 6, 2026 DarioHealth Corp. has announced a significant expansion of its digital health platform through a...
FARMVILLE, N.C., April 20, 2026 CMP Pharma, Inc. has announced the availability of a newly reformulated Norliqva® (amlodipine) oral...
Piramal Pharma Solutions, a global contract development and manufacturing organization (CDMO), has collaborated with George Medicines to develop WIDAPLIKâ„¢,...
